Article

Escalon completes MRP Group acquisition

Wayne, PA?Escalon Digital Vision Inc., a subsidiary of Escalon Medical Corp., has completed the acquisition of substantially all of the assets of MRP Group Inc., a privately held provider of ophthalmic technology solutions. The purchase price included 250,000 shares of Escalon Medical Corp.'s common stock and about $50,000 cash.

Wayne, PA-Escalon Digital Vision Inc., a subsidiary of Escalon Medical Corp., has completed the acquisition of substantially all of the assets of MRP Group Inc., a privately held provider of ophthalmic technology solutions. The purchase price included 250,000 shares of Escalon Medical Corp.'s common stock and about $50,000 cash.

Based in Lawrence, MA, MRP Group provides retinal and slit lamp imaging systems, office management software, and fundus camera power supplies.

Matthew Carnevale, MRP Group's founder and chief executive officer, will remain with Escalon as executive vice president of Escalon Digital Vision Inc.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
© 2025 MJH Life Sciences

All rights reserved.